A Comparitive Study Between Mirabegron And Tamsulosin For Ureteric Stent Related Morbidity
Phase 3
- Conditions
- Health Condition 1: N201- Calculus of ureter
- Registration Number
- CTRI/2021/01/030340
- Lead Sponsor
- Atif Abdullah C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients undergoing uretero-renoscopic lithotripsy with double J stent placement as treatment for ureteric calculus
Exclusion Criteria
Patients with bilatral stone disease, urosepsis, pregnancy, uncontrolled hypertension and residual stones
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method